Brian Bigger, PhD, leads the Stem Cell & Neurotherapies laboratory at the University of Manchester in Manchester U.K. The lab uses a multidisciplinary approach to investigate stem cell and gene therapies for neurological diseases, including Mucopolysaccharidosis (MPS) diseases such as MPS I (Hurler) and MPS IIIa (Sanfilippo).
In this exclusive interview with Rare Disease Report, Dr. Bigger described how his lab obtains funding and how that research may lead to a better understanding of not just rare diseases but also more common conditions. For more information about Dr. Bigger’s research, visit http://www.human-development.manchester.ac.uk/staff/BrianBigger/
Funding sources for Dr. Bigger’s lab include: